Acutaas Chemicals · NSE: ACUTAAS · BSE: 543349
Q4 FY26 results · Jan–Mar 2026
Acutaas Chemicals reported revenue from operations of ₹432.75 crore (up 40.3% from Q4 FY25) and net profit of ₹134.28 crore (up 114.1% from Q4 FY25) for Q4 FY26 (Jan–Mar 2026), on a consolidated basis.
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 432.75 | 308.48 | +40.3% | 393.18 | +10.1% |
| Other income | 11.11 | 5.78 | +92.3% | 4.70 | +136.4% |
| Total income | 443.86 | 314.26 | +41.2% | 397.88 | +11.6% |
| Profit before tax | 183.80 | 82.83 | +121.9% | 144.67 | +27.1% |
| Net profit for the period | 134.28 | 62.72 | +114.1% | 106.22 | +26.4% |
| Attributable to shareholders of the company | 131.76 | 62.48 | +110.9% | 107.96 | +22.0% |
| EPS, basic (₹) | 16.09 | 7.80 | +106.3% | 13.19 | +22.0% |
| Net margin (%) | 31.0 | 20.3 | 27.0 |
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 421.77 | 304.16 | +38.7% | 390.86 | +7.9% |
| Other income | 14.55 | 5.69 | +155.5% | 6.34 | +129.3% |
| Total income | 436.32 | 309.86 | +40.8% | 397.20 | +9.8% |
| Profit before tax | 185.86 | 82.81 | +124.4% | 150.70 | +23.3% |
| Net profit for the period | 137.07 | 62.85 | +118.1% | 111.57 | +22.9% |
| EPS, basic (₹) | 16.74 | 7.84 | +113.5% | 13.63 | +22.8% |
| Net margin (%) | 32.5 | 20.7 | 28.5 |
Consolidated
- Filed with BSE
- 30 Apr 2026, 19:04 IST
- Board meeting
- 30 Apr 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 30 Apr 2026, 19:04 IST
- Board meeting
- 30 Apr 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Unaudited
- Source
- XBRL filing on BSE